Elizabeth Marie Marfazelian, FNP

Elizabeth Marfazelian practices at Huntington Hospital - Unit in Pasadena, California.

Elizabeth Marfazelian's NPI, 1306201405, was assigned on December 16, 2015. Elizabeth Marfazelian holds California license 95003545.

Elizabeth Marfazelian's primary practice is Huntington Hospital - Unit, at 100 W. California Blvd, Pasadena, CA 91105 in Los Angeles County. The practice phone is (626) 397-2618.

Elizabeth Marfazelian's primary practice is Huntington Hospital - Unit in Pasadena, California. Elizabeth Marfazelian is also affiliated with Huntington Hospital. The medical group on file is Unio Specialty Care, Urology, Encinitas (formerly Genesis Healthcare Partners). Dmand AI also links Elizabeth Marfazelian to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Elizabeth Marfazelian practices, 3 sites in all. Vendor and product names are available with a free account.

Family is Elizabeth Marfazelian's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Elizabeth Marfazelian is licensed in California.

CMS data shows 36 Medicare services from Elizabeth Marfazelian across 2 procedure codes in 2024, for 40 Medicare patients. Medicare paid $1,548 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 40 Medicare patients who saw Elizabeth Marfazelian in 2024. The largest group is 75 to 84, with 17 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 48% are also on Medicaid. Their average risk score is 3.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Elizabeth Marfazelian's median patient age at 69, with 40% women.

In 2024, Elizabeth Marfazelian wrote 375 Medicare Part D claims for 117 patients. 83% of them were for generic drugs. CMS names the drug for 260 of them, across 7 drugs with 11 or more claims each, at $22,289 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Elizabeth Marfazelian for performance year 2024, reported as part of a group. Elizabeth Marfazelian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 5 general payments to Elizabeth Marfazelian from 3 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $173.